Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies. (Record no. 26577416)

MARC details
000 -LEADER
fixed length control field 01513 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517123409.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201703s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-764X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1080/14740338.2017.1257604
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Koutkias, Vassilis G
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170310
245 00 - TITLE STATEMENT
Title Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Expert opinion on drug safety
Date of publication, distribution, etc. Feb 2017
300 ## - PHYSICAL DESCRIPTION
Extent 113-124 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Validation Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adverse Drug Reaction Reporting Systems
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipsychotic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cardiotoxicity
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cerebral Hemorrhage
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clozapine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug-Related Side Effects and Adverse Reactions
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Factor Xa Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Haloperidol
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Information Storage and Retrieval
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacovigilance
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridones
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lillo-Le Louët, Agnès
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jaulent, Marie-Christine
773 0# - HOST ITEM ENTRY
Title Expert opinion on drug safety
Related parts vol. 16
-- no. 2
-- p. 113-124
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1080/14740338.2017.1257604">https://doi.org/10.1080/14740338.2017.1257604</a>
Public note Available from publisher's website

No items available.